165 related articles for article (PubMed ID: 31782160)
21. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity.
Coindre JM; Hostein I; Maire G; Derré J; Guillou L; Leroux A; Ghnassia JP; Collin F; Pedeutour F; Aurias A
J Pathol; 2004 Jul; 203(3):822-30. PubMed ID: 15221942
[TBL] [Abstract][Full Text] [Related]
22. New defining body (Ugras body) in polypoid dedifferentiated liposarcoma of the vallecula. Histomorphological, immunohistochemical and molecular genetic findings.
Ugras S; Miettinen M
Indian J Pathol Microbiol; 2020; 63(3):449-452. PubMed ID: 32769337
[TBL] [Abstract][Full Text] [Related]
23. Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours.
Aleixo PB; Hartmann AA; Menezes IC; Meurer RT; Oliveira AM
J Clin Pathol; 2009 Dec; 62(12):1127-35. PubMed ID: 19946100
[TBL] [Abstract][Full Text] [Related]
24. Application of MDM2 Fluorescence In Situ Hybridization and Immunohistochemistry in Distinguishing Dedifferentiated Liposarcoma From Other High-grade Sarcomas.
Song MJ; Cho KJ; Lee JS; Song JS
Appl Immunohistochem Mol Morphol; 2017; 25(10):712-719. PubMed ID: 27028243
[TBL] [Abstract][Full Text] [Related]
25. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.
Italiano A; Bianchini L; Keslair F; Bonnafous S; Cardot-Leccia N; Coindre JM; Dumollard JM; Hofman P; Leroux A; Mainguené C; Peyrottes I; Ranchere-Vince D; Terrier P; Tran A; Gual P; Pedeutour F
Int J Cancer; 2008 May; 122(10):2233-41. PubMed ID: 18214854
[TBL] [Abstract][Full Text] [Related]
26. Dedifferentiated Liposarcoma of the Gastroesophageal Junction.
Aşkan G; Bağci P; Hameed M; Baştürk O
Turk Patoloji Derg; 2018; 34(1):104-107. PubMed ID: 25690861
[TBL] [Abstract][Full Text] [Related]
27. Dedifferentiated liposarcoma with homologous lipoblastic differentiation: expanding the spectrum to include low-grade tumours.
Liau JY; Lee JC; Wu CT; Kuo KT; Huang HY; Liang CW
Histopathology; 2013 Apr; 62(5):702-10. PubMed ID: 23425231
[TBL] [Abstract][Full Text] [Related]
28. Expanding the differential of cutaneous epithelioid tumors: A case of dedifferentiated liposarcoma with epithelioid features involving the skin, with review of the literature.
Chambers M; Badin DJ; Sriharan AA; Linos KD
J Cutan Pathol; 2020 Jun; 47(6):554-560. PubMed ID: 31995237
[TBL] [Abstract][Full Text] [Related]
29. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
[TBL] [Abstract][Full Text] [Related]
30. Dedifferentiated Liposarcoma Masquerading as Rhabdomyosarcoma.
Kobayashi A; Hirose T; Kudo E; Kawashita Y; Yagi T
Appl Immunohistochem Mol Morphol; 2017; 25(5):e34-e36. PubMed ID: 27801731
[TBL] [Abstract][Full Text] [Related]
31.
Casadei L; Calore F; Braggio DA; Zewdu A; Deshmukh AA; Fadda P; Lopez G; Wabitsch M; Song C; Leight JL; Grignol VP; Lev D; Croce CM; Pollock RE
Cancer Res; 2019 Oct; 79(19):4911-4922. PubMed ID: 31387924
[TBL] [Abstract][Full Text] [Related]
32. [Retroperitoneal dedifferentiated liposarcoma with rhabdomyoblastic differentiation: a clinicopathological analysis].
Liu L; Wang LH; Ren YB; Rao XS; Yang SM
Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):94-98. PubMed ID: 29429159
[No Abstract] [Full Text] [Related]
33. Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down-regulation.
Zuco V; Pasquali S; Tortoreto M; Brich S; Percio S; Dagrada GP; Colombo C; Sanfilippo R; Lauricella C; Gounder M; El Bezawy R; Barisella M; Dei Tos AP; Casali PG; Gronchi A; Stacchiotti S; Zaffaroni N
J Exp Clin Cancer Res; 2021 Mar; 40(1):83. PubMed ID: 33648535
[TBL] [Abstract][Full Text] [Related]
34. Clarifying the Distinction Between Malignant Peripheral Nerve Sheath Tumor and Dedifferentiated Liposarcoma: A Critical Reappraisal of the Diagnostic Utility of MDM2 and H3K27me3 Status.
Makise N; Sekimizu M; Kubo T; Wakai S; Hiraoka N; Komiyama M; Fukayama M; Kawai A; Ichikawa H; Yoshida A
Am J Surg Pathol; 2018 May; 42(5):656-664. PubMed ID: 29309298
[TBL] [Abstract][Full Text] [Related]
35. Dedifferentiated liposarcoma of the spermatic cord with a hemangioendothelioma-like component: a case report and review of the literature.
Okano S; Yamamoto H; Kono S; Fujii H; Shirabe K; Maehara Y; Oda Y
Pathol Res Pract; 2013 Sep; 209(9):596-604. PubMed ID: 23910173
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis.
Creytens D; Van Gorp J; Speel EJ; Ferdinande L
Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836
[TBL] [Abstract][Full Text] [Related]
37. Co-expression of MDM2 and CDK4 in transformed human mesenchymal stem cells causes high-grade sarcoma with a dedifferentiated liposarcoma-like morphology.
Kim YJ; Kim M; Park HK; Yu DB; Jung K; Song K; Choi YL
Lab Invest; 2019 Sep; 99(9):1309-1320. PubMed ID: 31160689
[TBL] [Abstract][Full Text] [Related]
38. Primary cardiac dedifferentiated liposarcoma with homologous and heterologous differentiation: a case report.
He D; Chen M; Chen H; Liao D; Wang X; Zhang Z; Zhang H
Int J Clin Exp Pathol; 2015; 8(8):9662-6. PubMed ID: 26464734
[TBL] [Abstract][Full Text] [Related]
39. Primary duodenal dedifferentiated liposarcoma: A case report and literature review.
Kim NI; Lee JS; Choi C; Nam JH; Choi YD; Kim HJ; Kim SS
World J Clin Cases; 2022 Feb; 10(6):2007-2014. PubMed ID: 35317136
[TBL] [Abstract][Full Text] [Related]
40. Chromosome-12 copy number alterations and MDM2, CDK4 and TP53 expression in soft tissue liposarcoma.
Segura-Sánchez J; González-Cámpora R; Pareja-Megia MJ; García-Escudero A; Galera-Ruiz H; López-Beltrán A
Anticancer Res; 2006; 26(6C):4937-42. PubMed ID: 17214366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
